SCHEMBL9604628

SCHEMBL9604628

BC(C)CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12164023 0.90
SCHEMBL17002470 0.88 OPRM1 (0.50)
SCHEMBL13564506 0.88 OPRM1 (0.50)
SCHEMBL14072212 0.88 OPRM1 (0.50)
SCHEMBL13985798 0.88 OPRM1 (0.50)
SCHEMBL12452029 0.88 OPRM1 (0.50)
SCHEMBL7956247 0.88 OPRM1 (0.50)
SCHEMBL17002463 0.88 OPRM1 (0.50)
SCHEMBL14639849 0.88 OPRM1 (0.50)
SCHEMBL18104779 0.81 ACE2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035121-B1 MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS SHINETSU CHEMICAL CO (JP) 2019-03-13 EP disclosed
EP-1773869-B1 MACROCYCLIC MODULATORS OF THE GHRELIN RECEPTOR TRANZYME PHARMA INC (CA) 2012-08-22 EP disclosed
EP-2457962-A2 Ink set, ink cartridge, inkjet printer, inkjet recording method, and recorded matter Fujifilm Corporation (JP) 2012-05-30 EP disclosed
US-7923547-B2 for antisense therapy SIRNA THERAPEUTICS, INC. (US) 2011-04-12 US disclosed